Form 4: Sionna Therapeutics Executive Receives Stock Grant

Sentiment:

Insider Transaction (Form 4)


Jennifer Fitzpatrick, CLO and Head of Program Mgmt. of Sionna Therapeutics, Inc., reported multiple transactions in common stock on September 17, 2026.

Summary

  • Grant/award: acquired 28,133 Common Stock on September 17, 2026; holds 28,133 after (Direct).
  • Grant/award: acquired 28,132 Common Stock on September 17, 2026; holds 56,265 after (Direct).
  • Grant/award: acquired 103,140 Non-Qualified Stock Option (right to buy) on September 17, 2026; holds 103,140 after (Direct).
  • Disposition to the issuer: disposed of 103,140 Non-Qualified Stock Option (right to buy) on September 17, 2026 (Direct).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

Jennifer Fitzpatrick — Officer (CLO and Head of Program Mgmt.)

DateTransactionSecuritySharesPriceValueHeld After
2026-09-17Grant/awardCommon Stock28,133——28,133
2026-09-17Grant/awardCommon Stock28,132——56,265
2026-09-17Grant/awardNon-Qualified Stock Option (right to buy)103,140——103,140
2026-09-17Disposition to the issuerNon-Qualified Stock Option (right to buy)103,140——0

Key Dates

DateDescription
2026-09-17Grant/award (28,133 shares)
2026-09-17Grant/award (28,132 shares)
2026-09-17Grant/award (103,140 shares)
2026-09-17Disposition to the issuer (103,140 shares)

Keywords

insider transaction, Form 4, SION, Sionna Therapeutics, Inc., neutral, Jennifer Fitzpatrick

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.